[Pharmacodynamic aspects of a new coronary dilator: (3,4,5, trimethoxycinnamoil)-1 (ethylacetate)-4-piperazine maleate (6753)].
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002934:Cinnamates / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D005069:Evaluation Studies as Topic; D006168:Guinea Pigs; D007928:Lethal Dose 50; D051379:Mice; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000633:toxicity
D000085:Acetates; D002934:Cinnamates; D010879:Piperazines; D014665:Vasodilator Agents
Aspetti farmacodinamici di un nuovo coronariodilatatore: il maleato di (3,4,5, trimetossicinnamoil)-1 (acetato di etile)-4-piperazina (6753.